MARKET

BNTC

BNTC

Benitec Biopharm
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.080
+0.060
+5.88%
Closed 16:00 05/19 EDT
OPEN
1.080
PREV CLOSE
1.020
HIGH
1.160
LOW
1.030
VOLUME
31.65K
TURNOVER
26.04K
52 WEEK HIGH
5.07
52 WEEK LOW
1.020
MARKET CAP
8.83M
P/E (TTM)
-0.4157
1D
5D
1M
3M
1Y
5Y
Benitec GAAP EPS of -$0.40 beats by $0.04, revenue of $0.48M
Benitec press release (NASDAQ:BNTC): Q3 GAAP EPS of -$0.40 beats by $0.04. Revenue of $0.48M.
Seekingalpha · 3d ago
Benitec Biopharma Q3 EPS $(0.40) Up From $(0.82) YoY, Sales $48.00K Up From $1.00K YoY
Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.40) per share. This is a 51.22 percent increase over losses of $(0.82) per share from the same period last year. The company reported $48.00 thousand in
Benzinga · 3d ago
Benitec Biopharma Releases Q3 2022 Financial Results
HAYWARD, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “the Company”), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed ...
GlobeNewswire · 3d ago
BRIEF-Benitec Biopharma Inc - QTRLY Loss Per Share $0.40
reuters.com · 3d ago
-- Earnings Flash (BNTC) BENITEC BIOPHARMA Posts Q3 Revenue $48,000
MT Newswires · 3d ago
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's session saw 211 companies set new 52-week lows.
Benzinga · 05/03 16:20
Stocks That Hit 52-Week Lows On Monday
  On Monday morning, 66 companies achieved new lows for the year.
Benzinga · 02/28 15:43
Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2022
Upgrades
Benzinga · 02/17 15:02
More
No Data
Learn about the latest financial forecast of BNTC. Analyze the recent business situations of Benitec Biopharm through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
100.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average BNTC stock price target is 14.00 with a high estimate of 14.00 and a low estimate of 14.00.
High14.00
Average14.00
Low14.00
Current 1.080
EPS
Actual
Estimate
-9.88-7.41-4.94-2.47
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Institutional Holdings
Institutions: 22
Institutional Holdings: 1.72M
% Owned: 21.06%
Shares Outstanding: 8.17M
TypeInstitutionsShares
Increased
5
96.78K
New
1
66
Decreased
1
12.47K
Sold Out
2
15.13K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+2.00%
Pharmaceuticals & Medical Research
+0.51%
Key Executives
Chairman/Director
Jerel Banks
Chief Executive Officer/Secretary
Gregory West
Chief Financial Officer
Bryan Dulhunty
Chief Scientific Officer
Michael Graham
Secretary
Oliver Kidd
Director
Kevin Buchi
Non-Executive Director
Megan Boston
Non-Executive Director
Peter Francis
No Data
No Data
About BNTC
Benitec Biopharma Inc is an Australia-based biotechnology company. The Company is focused on developing a therapeutic technology platform that combines ribonucleic acid (RNA) interference with gene therapy for the goal of silencing disease-causing genes from a single administration. The Company's technology, deoxyribonucleic acid (DNA)-directed RNA interference (ddRNAi), is used to develop product candidates in chronic and life-threatening human disease areas including orphan disease and infectious disease. Its pipeline includes BB-301, and BB-103. The Company's lead product candidate, BB-301, is used for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD). Its BB-103 pipeline product is being developed for the treatment of chronic hepatitis B Virus infection.

Webull offers kinds of Benitec Biopharma Inc stock information, including NASDAQ:BNTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BNTC stock methods without spending real money on the virtual paper trading platform.